Focal Choroidal Excavation Complicated by Choroidal Neovascularization

To evaluate the clinical findings of focal choroidal excavation (FCE) complicated by choroidal neovascularization (CNV). Retrospective, observational case series. Twelve patients (15 eyes) with FCE and CNV. The medical records of the patients were reviewed. Clinical findings including age, sex, refr...

Full description

Saved in:
Bibliographic Details
Published inOphthalmology (Rochester, Minn.) Vol. 121; no. 1; pp. 246 - 250
Main Authors Xu, Haifeng, Zeng, Fanxing, Shi, Depeng, Sun, Xiaolei, Chen, Xiuli, Bai, Yao
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.01.2014
Subjects
Online AccessGet full text

Cover

Loading…
Abstract To evaluate the clinical findings of focal choroidal excavation (FCE) complicated by choroidal neovascularization (CNV). Retrospective, observational case series. Twelve patients (15 eyes) with FCE and CNV. The medical records of the patients were reviewed. Clinical findings including age, sex, refraction, color photography, fundus fluorescein angiography (FFA), indocyanine green angiography (ICGA), and spectral-domain optical coherence tomography (OCT) were analyzed. Fundus fluorescein angiography, ICGA, and OCT findings. The 12 patients included 6 women and 6 men. The mean age was 46.8±13.4 years (range, 26-64 years). One half of the patients were emmetropic, and the others were myopic (−0.5 to −3.0 diopters). All subjects were Chinese. Before CNV development, normal appearance or nonspecific pigment disturbance could be seen around the choroidal excavation. Corresponding to the excavation, window defects were observed by FFA, whereas hypofluorescence was found on ICGA images. Choroidal neovascularization in all eyes was classic as revealed by FFA. The OCT images showed that all eyes had a single choroidal excavation. In 7 of the 15 eyes, the choroidal excavation was located subfoveally, and in the other 8 eyes, it was eccentric. All CNV lesions grew from the bottom or slope of the excavation. Three patients had bilateral involvement. Choroidal neovascularization occurred in both conforming and nonconforming type FCEs, regardless of whether the excavation was shallow or deep, subfoveal or eccentric. All CNV lesions responded well to intravitreal injection of anti–vascular endothelial growth factor (VEGF) agents. After a single injection, CNV regressed in 13 of 15 eyes. Two eyes received an additional injection. Nonconforming FCE changed to the conforming type after successful treatment of CNV. Focal choroidal excavation is not always stable. Choroidal neovascularization commonly can be seen in patients with FCE and responds well to intravitreal anti-VEGF agents.
AbstractList To evaluate the clinical findings of focal choroidal excavation (FCE) complicated by choroidal neovascularization (CNV).PURPOSETo evaluate the clinical findings of focal choroidal excavation (FCE) complicated by choroidal neovascularization (CNV).Retrospective, observational case series.DESIGNRetrospective, observational case series.Twelve patients (15 eyes) with FCE and CNV.PARTICIPANTSTwelve patients (15 eyes) with FCE and CNV.The medical records of the patients were reviewed. Clinical findings including age, sex, refraction, color photography, fundus fluorescein angiography (FFA), indocyanine green angiography (ICGA), and spectral-domain optical coherence tomography (OCT) were analyzed.METHODSThe medical records of the patients were reviewed. Clinical findings including age, sex, refraction, color photography, fundus fluorescein angiography (FFA), indocyanine green angiography (ICGA), and spectral-domain optical coherence tomography (OCT) were analyzed.Fundus fluorescein angiography, ICGA, and OCT findings.MAIN OUTCOME MEASURESFundus fluorescein angiography, ICGA, and OCT findings.The 12 patients included 6 women and 6 men. The mean age was 46.8±13.4 years (range, 26-64 years). One half of the patients were emmetropic, and the others were myopic (-0.5 to -3.0 diopters). All subjects were Chinese. Before CNV development, normal appearance or nonspecific pigment disturbance could be seen around the choroidal excavation. Corresponding to the excavation, window defects were observed by FFA, whereas hypofluorescence was found on ICGA images. Choroidal neovascularization in all eyes was classic as revealed by FFA. The OCT images showed that all eyes had a single choroidal excavation. In 7 of the 15 eyes, the choroidal excavation was located subfoveally, and in the other 8 eyes, it was eccentric. All CNV lesions grew from the bottom or slope of the excavation. Three patients had bilateral involvement. Choroidal neovascularization occurred in both conforming and nonconforming type FCEs, regardless of whether the excavation was shallow or deep, subfoveal or eccentric. All CNV lesions responded well to intravitreal injection of anti-vascular endothelial growth factor (VEGF) agents. After a single injection, CNV regressed in 13 of 15 eyes. Two eyes received an additional injection. Nonconforming FCE changed to the conforming type after successful treatment of CNV.RESULTSThe 12 patients included 6 women and 6 men. The mean age was 46.8±13.4 years (range, 26-64 years). One half of the patients were emmetropic, and the others were myopic (-0.5 to -3.0 diopters). All subjects were Chinese. Before CNV development, normal appearance or nonspecific pigment disturbance could be seen around the choroidal excavation. Corresponding to the excavation, window defects were observed by FFA, whereas hypofluorescence was found on ICGA images. Choroidal neovascularization in all eyes was classic as revealed by FFA. The OCT images showed that all eyes had a single choroidal excavation. In 7 of the 15 eyes, the choroidal excavation was located subfoveally, and in the other 8 eyes, it was eccentric. All CNV lesions grew from the bottom or slope of the excavation. Three patients had bilateral involvement. Choroidal neovascularization occurred in both conforming and nonconforming type FCEs, regardless of whether the excavation was shallow or deep, subfoveal or eccentric. All CNV lesions responded well to intravitreal injection of anti-vascular endothelial growth factor (VEGF) agents. After a single injection, CNV regressed in 13 of 15 eyes. Two eyes received an additional injection. Nonconforming FCE changed to the conforming type after successful treatment of CNV.Focal choroidal excavation is not always stable. Choroidal neovascularization commonly can be seen in patients with FCE and responds well to intravitreal anti-VEGF agents.CONCLUSIONSFocal choroidal excavation is not always stable. Choroidal neovascularization commonly can be seen in patients with FCE and responds well to intravitreal anti-VEGF agents.
To evaluate the clinical findings of focal choroidal excavation (FCE) complicated by choroidal neovascularization (CNV). Retrospective, observational case series. Twelve patients (15 eyes) with FCE and CNV. The medical records of the patients were reviewed. Clinical findings including age, sex, refraction, color photography, fundus fluorescein angiography (FFA), indocyanine green angiography (ICGA), and spectral-domain optical coherence tomography (OCT) were analyzed. Fundus fluorescein angiography, ICGA, and OCT findings. The 12 patients included 6 women and 6 men. The mean age was 46.8±13.4 years (range, 26-64 years). One half of the patients were emmetropic, and the others were myopic (−0.5 to −3.0 diopters). All subjects were Chinese. Before CNV development, normal appearance or nonspecific pigment disturbance could be seen around the choroidal excavation. Corresponding to the excavation, window defects were observed by FFA, whereas hypofluorescence was found on ICGA images. Choroidal neovascularization in all eyes was classic as revealed by FFA. The OCT images showed that all eyes had a single choroidal excavation. In 7 of the 15 eyes, the choroidal excavation was located subfoveally, and in the other 8 eyes, it was eccentric. All CNV lesions grew from the bottom or slope of the excavation. Three patients had bilateral involvement. Choroidal neovascularization occurred in both conforming and nonconforming type FCEs, regardless of whether the excavation was shallow or deep, subfoveal or eccentric. All CNV lesions responded well to intravitreal injection of anti–vascular endothelial growth factor (VEGF) agents. After a single injection, CNV regressed in 13 of 15 eyes. Two eyes received an additional injection. Nonconforming FCE changed to the conforming type after successful treatment of CNV. Focal choroidal excavation is not always stable. Choroidal neovascularization commonly can be seen in patients with FCE and responds well to intravitreal anti-VEGF agents.
Purpose To evaluate the clinical findings of focal choroidal excavation (FCE) complicated by choroidal neovascularization (CNV). Design Retrospective, observational case series. Participants Twelve patients (15 eyes) with FCE and CNV. Methods The medical records of the patients were reviewed. Clinical findings including age, sex, refraction, color photography, fundus fluorescein angiography (FFA), indocyanine green angiography (ICGA), and spectral-domain optical coherence tomography (OCT) were analyzed. Main Outcome Measures Fundus fluorescein angiography, ICGA, and OCT findings. Results The 12 patients included 6 women and 6 men. The mean age was 46.8±13.4 years (range, 26-64 years). One half of the patients were emmetropic, and the others were myopic (−0.5 to −3.0 diopters). All subjects were Chinese. Before CNV development, normal appearance or nonspecific pigment disturbance could be seen around the choroidal excavation. Corresponding to the excavation, window defects were observed by FFA, whereas hypofluorescence was found on ICGA images. Choroidal neovascularization in all eyes was classic as revealed by FFA. The OCT images showed that all eyes had a single choroidal excavation. In 7 of the 15 eyes, the choroidal excavation was located subfoveally, and in the other 8 eyes, it was eccentric. All CNV lesions grew from the bottom or slope of the excavation. Three patients had bilateral involvement. Choroidal neovascularization occurred in both conforming and nonconforming type FCEs, regardless of whether the excavation was shallow or deep, subfoveal or eccentric. All CNV lesions responded well to intravitreal injection of anti–vascular endothelial growth factor (VEGF) agents. After a single injection, CNV regressed in 13 of 15 eyes. Two eyes received an additional injection. Nonconforming FCE changed to the conforming type after successful treatment of CNV. Conclusions Focal choroidal excavation is not always stable. Choroidal neovascularization commonly can be seen in patients with FCE and responds well to intravitreal anti-VEGF agents.
To evaluate the clinical findings of focal choroidal excavation (FCE) complicated by choroidal neovascularization (CNV). Retrospective, observational case series. Twelve patients (15 eyes) with FCE and CNV. The medical records of the patients were reviewed. Clinical findings including age, sex, refraction, color photography, fundus fluorescein angiography (FFA), indocyanine green angiography (ICGA), and spectral-domain optical coherence tomography (OCT) were analyzed. Fundus fluorescein angiography, ICGA, and OCT findings. The 12 patients included 6 women and 6 men. The mean age was 46.8±13.4 years (range, 26-64 years). One half of the patients were emmetropic, and the others were myopic (-0.5 to -3.0 diopters). All subjects were Chinese. Before CNV development, normal appearance or nonspecific pigment disturbance could be seen around the choroidal excavation. Corresponding to the excavation, window defects were observed by FFA, whereas hypofluorescence was found on ICGA images. Choroidal neovascularization in all eyes was classic as revealed by FFA. The OCT images showed that all eyes had a single choroidal excavation. In 7 of the 15 eyes, the choroidal excavation was located subfoveally, and in the other 8 eyes, it was eccentric. All CNV lesions grew from the bottom or slope of the excavation. Three patients had bilateral involvement. Choroidal neovascularization occurred in both conforming and nonconforming type FCEs, regardless of whether the excavation was shallow or deep, subfoveal or eccentric. All CNV lesions responded well to intravitreal injection of anti-vascular endothelial growth factor (VEGF) agents. After a single injection, CNV regressed in 13 of 15 eyes. Two eyes received an additional injection. Nonconforming FCE changed to the conforming type after successful treatment of CNV. Focal choroidal excavation is not always stable. Choroidal neovascularization commonly can be seen in patients with FCE and responds well to intravitreal anti-VEGF agents.
Author Sun, Xiaolei
Xu, Haifeng
Shi, Depeng
Bai, Yao
Zeng, Fanxing
Chen, Xiuli
Author_xml – sequence: 1
  givenname: Haifeng
  surname: Xu
  fullname: Xu, Haifeng
  email: chxhf@126.com
– sequence: 2
  givenname: Fanxing
  surname: Zeng
  fullname: Zeng, Fanxing
– sequence: 3
  givenname: Depeng
  surname: Shi
  fullname: Shi, Depeng
– sequence: 4
  givenname: Xiaolei
  surname: Sun
  fullname: Sun, Xiaolei
– sequence: 5
  givenname: Xiuli
  surname: Chen
  fullname: Chen, Xiuli
– sequence: 6
  givenname: Yao
  surname: Bai
  fullname: Bai, Yao
BackLink https://www.ncbi.nlm.nih.gov/pubmed/24095605$$D View this record in MEDLINE/PubMed
BookMark eNqVktFrFDEQxoNU7LX6H4jcoy-7TpLdTVZEKEdPC0UftNC3kE1muZy5zZnsHp5_vbleC0WQ4tPMw-_7hvlmzsjJEAYk5DWFkgJt3q3LsF2NK10yoLwEWQKtnpEZrau2qATlJ2SWMVo0FYNTcpbSGgCahlcvyCmroK0bqGdkuQxG-_liFWJwNneXv4ze6dGFYb4Im613Ro9o593-EfMFw04nM3kd3e879iV53muf8NV9PSc3y8vvi8_F9ddPV4uL68LUko2FRlNT2jEretNbi0w00nIqba0b3SFALUQtObeMAkeJVGveyB4sdrIF0_Nz8vbou43h54RpVBuXDHqvBwxTUrRqQUAjWpHRN_fo1G3Qqm10Gx336mH3DLw_AiaGlCL2yrjxbpsxaucVBXUIWq3VMWh1CFqBVDnoLK7-Ej_4PyH7eJRhDmnnMKpkHA4GrYtoRmWD-18D492Qj-R_4B7TOkxxyAdQVCWmQH07vMDhAygHEJzdZoMP_zZ4ev4fTJ_DMg
CitedBy_id crossref_primary_10_1186_s12886_024_03415_8
crossref_primary_10_1111_cxo_12309
crossref_primary_10_1111_cxo_12265
crossref_primary_10_1111_cxo_12590
crossref_primary_10_1016_j_oftal_2015_10_004
crossref_primary_10_1016_j_survophthal_2024_09_010
crossref_primary_10_3390_app12094472
crossref_primary_10_1080_09273948_2018_1540708
crossref_primary_10_1097_OPX_0000000000000530
crossref_primary_10_1155_2019_7925737
crossref_primary_10_1186_s12886_019_1081_6
crossref_primary_10_12688_f1000research_141099_1
crossref_primary_10_1155_2018_8406857
crossref_primary_10_1111_aos_14683
crossref_primary_10_1177_1120672120981364
crossref_primary_10_1007_s00417_019_04374_3
crossref_primary_10_1177_24741264241294159
crossref_primary_10_1097_IAE_0000000000002980
crossref_primary_10_3341_jkos_2019_60_6_541
crossref_primary_10_1038_eye_2015_31
crossref_primary_10_1097_OPX_0000000000000443
crossref_primary_10_1155_2016_7073083
crossref_primary_10_1097_IAE_0000000000001805
crossref_primary_10_18502_jovr_v15i3_7461
crossref_primary_10_1097_ICB_0000000000000617
crossref_primary_10_4103_ijo_IJO_931_20
crossref_primary_10_1038_s41433_018_0158_4
crossref_primary_10_1007_s00417_021_05487_4
crossref_primary_10_1159_000444681
crossref_primary_10_4103_ijo_IJO_569_20
crossref_primary_10_2147_OPTH_S264731
crossref_primary_10_1007_s00417_021_05445_0
crossref_primary_10_1136_bjophthalmol_2020_316992
crossref_primary_10_4103_ojo_ojo_73_23
crossref_primary_10_3928_23258160_20150101_24
crossref_primary_10_1016_j_ajoc_2021_101078
crossref_primary_10_1097_OPX_0000000000000956
crossref_primary_10_1136_bjophthalmol_2015_307055
crossref_primary_10_1177_1120672120932092
crossref_primary_10_1016_j_preteyeres_2016_04_002
crossref_primary_10_1016_j_heliyon_2024_e36246
crossref_primary_10_1016_j_oftale_2015_12_012
crossref_primary_10_1177_2474126419888135
crossref_primary_10_1097_ICB_0000000000000649
crossref_primary_10_1038_eye_2017_136
crossref_primary_10_4103_ijo_IJO_919_19
crossref_primary_10_1038_s41598_023_49153_7
crossref_primary_10_1007_s00417_021_05450_3
crossref_primary_10_1111_ceo_13775
crossref_primary_10_1177_11206721231198884
crossref_primary_10_4103_ojo_OJO_61_2018
crossref_primary_10_3389_fopht_2022_984903
crossref_primary_10_3390_bioengineering10030377
crossref_primary_10_1097_IAE_0000000000001345
crossref_primary_10_1038_eye_2017_71
crossref_primary_10_1097_IAE_0000000000003926
crossref_primary_10_1177_24741264241305116
crossref_primary_10_1016_j_jfo_2023_05_013
crossref_primary_10_1097_ICB_0000000000000833
crossref_primary_10_1016_j_ajoc_2020_100772
crossref_primary_10_1097_ICB_0000000000000759
Cites_doi 10.1097/01.iae.0000248819.86737.a5
10.2147/OPTH.S33879
10.1097/OPX.0b013e31828736f3
10.1001/archophthalmol.2011.148
10.1111/j.1755-3768.2010.01895.x
10.1097/IAE.0b013e31827b6452
ContentType Journal Article
Copyright 2014 American Academy of Ophthalmology
American Academy of Ophthalmology
Copyright © 2014 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.
Copyright_xml – notice: 2014 American Academy of Ophthalmology
– notice: American Academy of Ophthalmology
– notice: Copyright © 2014 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1016/j.ophtha.2013.08.014
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic



MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1549-4713
EndPage 250
ExternalDocumentID 24095605
10_1016_j_ophtha_2013_08_014
S016164201300732X
1_s2_0_S016164201300732X
Genre Journal Article
GroupedDBID ---
--K
.1-
.55
.FO
.GJ
0R~
123
1B1
1CY
1P~
1~5
29N
4.4
457
4G.
53G
5RE
5VS
7-5
71M
AAEDT
AAEDW
AALRI
AAQFI
AAQQT
AAQXK
AAXUO
ABCQX
ABFRF
ABJNI
ABLJU
ABMAC
ABOCM
ABWVN
ACGFO
ACGFS
ACIUM
ACNCT
ACRPL
ACVFH
ADCNI
ADMUD
ADNMO
AEFWE
AENEX
AEUPX
AEVXI
AFFNX
AFJKZ
AFPUW
AFRHN
AFTJW
AGCQF
AGQPQ
AIGII
AITUG
AJUYK
AKRWK
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
BELOY
C5W
CS3
DU5
EBS
EFJIC
EFKBS
EJD
F5P
FDB
FEDTE
FGOYB
GBLVA
HVGLF
HZ~
IHE
J1W
K-O
KOM
L7B
M27
M41
MO0
N4W
N9A
NQ-
O9-
OF-
OPF
OQ~
P2P
R2-
ROL
RPZ
SDG
SEL
SES
SSZ
UHS
UNMZH
UV1
WH7
X7M
XH2
XPP
Z5R
ZGI
ZXP
ADPAM
RIG
AAIAV
AGZHU
AHPSJ
ALXNB
ZA5
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-c582t-aec511b2d7fcfdde2768d318d5a6abe005775833d2103e8e1aa368f0deb890cf3
ISSN 0161-6420
1549-4713
IngestDate Mon Jul 21 09:57:27 EDT 2025
Thu Apr 03 07:06:31 EDT 2025
Tue Jul 01 03:37:31 EDT 2025
Thu Apr 24 22:53:12 EDT 2025
Fri Feb 23 02:14:11 EST 2024
Sun Feb 23 10:19:11 EST 2025
Tue Aug 26 16:36:58 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License https://www.elsevier.com/tdm/userlicense/1.0
Copyright © 2014 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c582t-aec511b2d7fcfdde2768d318d5a6abe005775833d2103e8e1aa368f0deb890cf3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink http://www.aaojournal.org/article/S016164201300732X/pdf
PMID 24095605
PQID 1490706797
PQPubID 23479
PageCount 5
ParticipantIDs proquest_miscellaneous_1490706797
pubmed_primary_24095605
crossref_citationtrail_10_1016_j_ophtha_2013_08_014
crossref_primary_10_1016_j_ophtha_2013_08_014
elsevier_sciencedirect_doi_10_1016_j_ophtha_2013_08_014
elsevier_clinicalkeyesjournals_1_s2_0_S016164201300732X
elsevier_clinicalkey_doi_10_1016_j_ophtha_2013_08_014
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate January 2014
2014
2014-01-00
2014-Jan
20140101
PublicationDateYYYYMMDD 2014-01-01
PublicationDate_xml – month: 01
  year: 2014
  text: January 2014
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Ophthalmology (Rochester, Minn.)
PublicationTitleAlternate Ophthalmology
PublicationYear 2014
Publisher Elsevier Inc
Publisher_xml – name: Elsevier Inc
References Obata, Takahashi, Ueta (bib4) 2013; 33
Jampol, Shankle, Schroeder (bib1) 2006; 26
Margolis, Mukkamala, Jampol (bib3) 2011; 129
Wakabayashi, Nishimura, Higashide (bib2) 2010; 88
Kobayashi, Abe, Tamai, Nakazawa (bib6) 2012; 6
Kumano, Nagai, Enaida (bib5) 2013; 90
Jampol (10.1016/j.ophtha.2013.08.014_bib1) 2006; 26
Kobayashi (10.1016/j.ophtha.2013.08.014_bib6) 2012; 6
Wakabayashi (10.1016/j.ophtha.2013.08.014_bib2) 2010; 88
Kumano (10.1016/j.ophtha.2013.08.014_bib5) 2013; 90
Margolis (10.1016/j.ophtha.2013.08.014_bib3) 2011; 129
Obata (10.1016/j.ophtha.2013.08.014_bib4) 2013; 33
References_xml – volume: 129
  start-page: 1320
  year: 2011
  end-page: 1325
  ident: bib3
  article-title: The expanded spectrum of focal choroidal excavation
  publication-title: Arch Ophthalmol
– volume: 90
  start-page: e110
  year: 2013
  end-page: e118
  ident: bib5
  article-title: Symptomatic and morphologic difference between choroidal excavations
  publication-title: Optom Vis Sci
– volume: 88
  start-page: e87
  year: 2010
  end-page: e91
  ident: bib2
  article-title: Unilateral choroidal excavation in the macula detected by spectral-domain optical coherence tomography
  publication-title: Acta Ophthalmol
– volume: 33
  start-page: 1201
  year: 2013
  end-page: 1210
  ident: bib4
  article-title: Tomographic and angiographic characteristics of eyes with macular focal choroidal excavation
  publication-title: Retina
– volume: 6
  start-page: 1373
  year: 2012
  end-page: 1376
  ident: bib6
  article-title: Choroidal excavation with polypoidalchoroidal vasculopathy: a case report
  publication-title: Clin Ophthalmol
– volume: 26
  start-page: 1072
  year: 2006
  end-page: 1076
  ident: bib1
  article-title: Diagnostic and therapeutic challenges
  publication-title: Retina
– volume: 26
  start-page: 1072
  year: 2006
  ident: 10.1016/j.ophtha.2013.08.014_bib1
  article-title: Diagnostic and therapeutic challenges
  publication-title: Retina
  doi: 10.1097/01.iae.0000248819.86737.a5
– volume: 6
  start-page: 1373
  year: 2012
  ident: 10.1016/j.ophtha.2013.08.014_bib6
  article-title: Choroidal excavation with polypoidalchoroidal vasculopathy: a case report
  publication-title: Clin Ophthalmol
  doi: 10.2147/OPTH.S33879
– volume: 90
  start-page: e110
  year: 2013
  ident: 10.1016/j.ophtha.2013.08.014_bib5
  article-title: Symptomatic and morphologic difference between choroidal excavations
  publication-title: Optom Vis Sci
  doi: 10.1097/OPX.0b013e31828736f3
– volume: 129
  start-page: 1320
  year: 2011
  ident: 10.1016/j.ophtha.2013.08.014_bib3
  article-title: The expanded spectrum of focal choroidal excavation
  publication-title: Arch Ophthalmol
  doi: 10.1001/archophthalmol.2011.148
– volume: 88
  start-page: e87
  year: 2010
  ident: 10.1016/j.ophtha.2013.08.014_bib2
  article-title: Unilateral choroidal excavation in the macula detected by spectral-domain optical coherence tomography
  publication-title: Acta Ophthalmol
  doi: 10.1111/j.1755-3768.2010.01895.x
– volume: 33
  start-page: 1201
  year: 2013
  ident: 10.1016/j.ophtha.2013.08.014_bib4
  article-title: Tomographic and angiographic characteristics of eyes with macular focal choroidal excavation
  publication-title: Retina
  doi: 10.1097/IAE.0b013e31827b6452
SSID ssj0006634
Score 2.3973925
Snippet To evaluate the clinical findings of focal choroidal excavation (FCE) complicated by choroidal neovascularization (CNV). Retrospective, observational case...
Purpose To evaluate the clinical findings of focal choroidal excavation (FCE) complicated by choroidal neovascularization (CNV). Design Retrospective,...
To evaluate the clinical findings of focal choroidal excavation (FCE) complicated by choroidal neovascularization (CNV).PURPOSETo evaluate the clinical...
SourceID proquest
pubmed
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 246
SubjectTerms Adult
Angiogenesis Inhibitors - therapeutic use
Choroid - pathology
Choroidal Neovascularization - diagnosis
Choroidal Neovascularization - drug therapy
Choroidal Neovascularization - etiology
Coloring Agents
Female
Fluorescein Angiography
Humans
Indocyanine Green
Intravitreal Injections
Male
Middle Aged
Ophthalmology
Retrospective Studies
Tomography, Optical Coherence
Vascular Endothelial Growth Factor A - antagonists & inhibitors
Visual Acuity
Title Focal Choroidal Excavation Complicated by Choroidal Neovascularization
URI https://www.clinicalkey.com/#!/content/1-s2.0-S016164201300732X
https://www.clinicalkey.es/playcontent/1-s2.0-S016164201300732X
https://dx.doi.org/10.1016/j.ophtha.2013.08.014
https://www.ncbi.nlm.nih.gov/pubmed/24095605
https://www.proquest.com/docview/1490706797
Volume 121
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnR3batswVGQtjL2M7tqs2_Bgb8PBli-yH0vaUBbawdaysBchyxJxyezS2NDtW_axPbrYdZqGdn0xxpIsWefo3HwuCH1mPA8ykgUu8RLphhL0lJTFoLVyGXEsEmDp2tviJD46C7_Ootlg8K_ntdTU2Yj_vTOu5DFQhWcAVxUl-x-Q7V4KD-Ae4AtXgDBcHwTjiWJEX8bz6rIqcpUg-IozY2LV59zEt2kJ86bPiei8T20IZl8-_XYxr-ds8dtkZtLmBVtRy_jYl-WoZzuYNZpzsUIKQzKOD4yRpnMj_mUbJqy8Kto-nVVnbqLcVR3e202NpoazglULUfTarIHChIS21kqAOig43gq5NRHRK3hliac1Rho-jE1C2jUSb6wN56NKb4hyzgt0ElY78UpG7cPx1HeXeOS5P9Ra1FLU7zsS6BLutzNt-3SJqUfXuj5B2xiUECD72_vT7z-nHacHac3mjjef2YZmav_B9fVtEn02qTZaxDndQc-tbuLsG0R7gQaifImeHlvvi1doovHN6XDJucE3p4dvTvan12cd316js8nh6fjItXU4XB4luHaZ4CCWZzgnkktghxhU1Bx4QR6xmGVCxTMTFbyXY98LRCJ8xoI4kV4usiSFQx-8QVtlVYpd5KTK_zeUnsSEhYRJJoGGRCyTXOR5KPEQBe0WUW6T1KtaKQvaeiOeU7OxVG0sVSVU_XCI3G7UhUnSck__qN192gYgA8ukgGL3jCN3jRNLSxOWdBMK9Uda0daIrA-Y81OLHhQov_qdx0pRNTBXmAK_jklKhuitwZvu60FOV4aP6N2jV7yHnqnDbKyN79FWfdmIDyB_19lHewyuAdJD1k8
linkProvider Library Specific Holdings
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Focal+Choroidal+Excavation+Complicated+by+Choroidal+Neovascularization&rft.jtitle=Ophthalmology+%28Rochester%2C+Minn.%29&rft.au=Xu%2C+Haifeng%2C+MD%2C+PhD&rft.au=Zeng%2C+Fanxing%2C+MD&rft.au=Shi%2C+Depeng%2C+MD&rft.au=Sun%2C+Xiaolei%2C+MD&rft.date=2014&rft.issn=0161-6420&rft.volume=121&rft.issue=1&rft.spage=246&rft.epage=250&rft_id=info:doi/10.1016%2Fj.ophtha.2013.08.014&rft.externalDBID=ECK1-s2.0-S016164201300732X&rft.externalDocID=1_s2_0_S016164201300732X
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F01616420%2FS0161642013X00119%2Fcov150h.gif